Skip to search formSkip to main contentSkip to account menu

VBY-825

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Hydrocarbons, FluorinatedSulfones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Abstract 1803: A new spectrum-selective cathepsin inhibitor, VBY-825, inhibits bone destruction in a syngeneic 5TGM1 multiple myeloma mouse model
Multiple myeloma (MM) is the second most common blood cancer after non Hodgkin lymphoma. It is a monoclonal B-cell neoplasia with… 
2013
2013
Novel Mechanisms and Therapeutics in the Treatment for Cancer-Induced Bone Pain
Many common cancers, including breast, prostate and lung, have a predilection to metastasize to the bone, bringing not only bone… 
2013
2013
Multivalent Cathepsin Inhibitor, VBY-825, Attenuates Breast-Induced Bone Cancer Remodelling and Pain
Metastatic bone cancer originates from breast malignancies causing severe pain and bone destruction in patients. Amongst the… 
2011
2011
Cathepsin Inhibitor, VBY-825, Attenuates Bone Cancer Induced Pain in Mice
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)